| Trial ID: | L6913 |
| Source ID: | NCT01492205
|
| Associated Drug: |
Insulin Human
|
| Title: |
NovoLet® Acceptance Study Within the Hospital Practise in Indonesia
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: insulin human
|
| Outcome Measures: |
Primary: Overall acceptance of the NovoLet® system among healthcare professionals (nurses and doctors) | Secondary: Time taken for the healthcare professionals (nurses and doctors) to teach the patient|Incidence of adverse drug reactions
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
203
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2005-09
|
| Completion Date: |
2006-06
|
| Results First Posted: |
|
| Last Update Posted: |
2016-10-14
|
| Locations: |
Novo Nordisk Investigational Site, Jakarta, 12520, Indonesia
|
| URL: |
https://clinicaltrials.gov/show/NCT01492205
|
